Back

Performance of the 2020 ACC/AHA and 2023 ESC risk stratification scales for primary prevention of sudden cardiac death in a Latin American population with hypertrophic cardiomyopathy

1 September 2024 (07:55 - 08:50)
Organised by: Logo
Congress Presentation Part of: Novel insights into Brugada syndrome and hypertrophic cardiomyopathy Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Juan Pablo Casillas Munoz

National Institute of Cardiology Ignacio Chavez, Mexico City (Mexico)

7 More presentations in this session

Presentation thumbnail
Relationship between epicardial adipose tissue and ventricular fibrillation in Brugada syndrome by cardiac computed tomography analysis
Mr K. Yonezu (Yufu City, JP)
Abstract Slides Video
Presentation thumbnail
Prognostic parameters predict cardiac events in Brugada syndrome: a meta-analysis
Mr P. Pajareya (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Refining risk stratification in hypertrophic cardiomyopathy: the role of late gadolinium enhancement and syncope in predicting adverse outcomes
Doctor C. Mann (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Novel electric predictors of lethal arrhythmic event in patients with hypertrophic cardiomyopathy
Professor J. Choi (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Prevalence of cardiovascular comorbidities among hospitalized patients with hypertrophic cardiomyopathy and factors associated with a higher case-fatality rate
Doctor S. Shoar (Largo, US)
Abstract Slides Video

Access the full session

Session thumbnail
Novel insights into Brugada syndrome and hypertrophic cardiomyopathy

The Event

Event poster

ESC Congress 2024

1 September 2024 07:55 CET
You may be interested in
thumbnail
Congress Presentation
Time-trends in the decision of a primary prevention strategy implementation in patients with hypertrophic cardiomyopathy
13 May 2024
thumbnail
Congress Presentation
Performance of the PREVENT risk score for atherosclerotic cardiovascular disease in a diverse population-based cohort study: comparative assessment against the recalibrated WHO CVD risk score
30 August 2025
thumbnail
Congress Presentation
The challenge of risk stratification in hypertrophic cardiomyopathy: clinical, genetic and imaging insights from a quaternary referral centre
27 August 2023
thumbnail
Congress Presentation
Comparison of characteristics and outcomes of patients with obstructive vs. non-obstructive hypertrophic cardiomyopathy in a cohort from a referral center in colombia
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources